CAM
Cormorant Asset Management Portfolio holdings
AUM
$1.34B
This Quarter Return
+12.98%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$1.24B
AUM Growth
+$1.24B
(+7.8%)
Cap. Flow
+$168M
Cap. Flow
% of AUM
13.47%
Top 10 Holdings %
Top 10 Hldgs %
48.36%
Holding
62
New
13
Increased
6
Reduced
5
Closed
6
Top Buys
| 1 |
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
|
$43.1M |
| 2 |
AUTL
Autolus Therapeutics
AUTL
|
$40.9M |
| 3 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$27.9M |
| 4 |
Kezar Life Sciences
KZR
|
$27.2M |
| 5 |
SPPI
Spectrum Pharmaceuticals Inc
SPPI
|
$25.2M |
Top Sells
| 1 |
Nektar Therapeutics
NKTR
|
$51.9M |
| 2 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$23.7M |
| 3 |
VYNE Therapeutics
VYNE
|
$12.7M |
| 4 |
Clearside Biomedical
CLSD
|
$7.28M |
| 5 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
$7.01M |
Sector Composition
| 1 | Healthcare | 95.91% |
